1
|
Flores J, Moriarty A, Lizette F, Lang A, Rosenthal A, Papadopoulos K, Beeram M, Patnaik A, Rasco D, DeBerry B, Elmi M, Drengler R, Hernandez T, Sharma M, Lakhani N, Smith L, Moreno V, Calvo E, Garcia-Foncillas J, Wick M. Identification and molecular characterization of invasive lobular breast cancer models in a panel of 180 breast XPDX models. Eur J Cancer 2022. [DOI: 10.1016/s0959-8049(22)01121-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
2
|
Elmi M. Health Alliance for Digital Development and Action (HADDA). Eur J Public Health 2020. [DOI: 10.1093/eurpub/ckaa165.1149] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
SPIDER's Digital Health Programme in Somalia - HADDA - supports Somalia's National Plan for health system strengthening through the use of digital tools for data and knowledge sharing. By deploying and tailoring a Health Information Management System for the country's health system, the programme will enhance the capacity of healthcare workers, whilst enabling policy makers to analyse public health data, plan, manage and deliver quality healthcare for all in Somalia. To realise this, a number of Maternal and Child Health Clinics and referral services will be selected that will connect the entire care pathway in Puntland and Galmudug linking them to the Federal Ministry of Health. Based on the outcome of a needs-assessment in the selected regions, the evidence will determine the required digital infrastructure and human resources and skills necessary for the programme to succeed. SPIDER, in alliance with the Somali government authorities, will engage and mobilise key stakeholders, practically adhering to the digital principles for development for the strengthening of the health system. In tandem with the implementation of project activities, SPIDER will support an independent and ongoing research programme to monitor the outcomes of programme. This will help to improve the methods of application, manage risks, and sustain the results.
Collapse
Affiliation(s)
- M Elmi
- SPIDER, Stockholm University, Stockholm, Sweden
| |
Collapse
|
3
|
Elmi M, Tigert A, Escallon J, Zagorski B, Leong W, Vranic M, Fyles A, Vitkin A, Cil T, McCready D. Abstract P3-12-02: Intraoperative radiotherapy outcomes in early-stage breast cancer: A study in elderly Canadian women. Cancer Res 2019. [DOI: 10.1158/1538-7445.sabcs18-p3-12-02] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Objective. Breast-conserving therapy with external beam radiotherapy (EBRT) is currently the standard of care for women with early breast cancer. Our aim was to determine if early-stage breast cancers treated with lumpectomy and primary intraoperative radiotherapy (IORT) have comparable local recurrence rates. This is the first study examining the Canadian experience with IORT.
Methods. Patients who underwent breast-conserving therapy with pre-pathology IORT between 2007- 2017 were retrospectively identified. The primary outcome measure was ipsilateral breast tumor recurrence (IBRT). A time to event analysis was performed; Kaplan-Meier estimates report the fraction of patients living free of recurrence. Secondary outcomes included acute and chronic wound complications.
Results. 106 patients with a median age of 70 (IQR 65-75) were included. Median follow-up was 33 months. The majority of patients had screen-detected (94.3%), estrogen-receptor positive (96.2%), HER2neu negative (93.4%), invasive ductal carcinomas (92.5%). Only 50 (47.6%) were prescribed adjuvant endocrine blockade. IBTR occurred in 5 (4.7%) patients. Five and ten-year local recurrence-free rates were 0.95 and 0.81, respectively. The superficial skin infection rate was 9.4%. Acute symptomatic seromas occurred in 23 (21.7%), while only 10 (9.4%) persisted chronically.
Conclusion. In this cohort of Canadian post-menopausal women treated with breast-conserving surgery and IORT, the IBTR approached 5%. Despite selection of low-risk patients, the local recurrence rate is higher than what is reported in the literature with EBRT. The low rates of prescribed adjuvant systemic therapy may have contributed to this outcome.
Citation Format: Elmi M, Tigert A, Escallon J, Zagorski B, Leong W, Vranic M, Fyles A, Vitkin A, Cil T, McCready D. Intraoperative radiotherapy outcomes in early-stage breast cancer: A study in elderly Canadian women [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr P3-12-02.
Collapse
Affiliation(s)
- M Elmi
- UT Texas Health San Antonio, San Antonio, TX; Faculty of Medicine, University of Toronto, Toronto, ON, Canada; Princess Margaret Cancer Center, University Health Network, Toroto, ON, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada
| | - A Tigert
- UT Texas Health San Antonio, San Antonio, TX; Faculty of Medicine, University of Toronto, Toronto, ON, Canada; Princess Margaret Cancer Center, University Health Network, Toroto, ON, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada
| | - J Escallon
- UT Texas Health San Antonio, San Antonio, TX; Faculty of Medicine, University of Toronto, Toronto, ON, Canada; Princess Margaret Cancer Center, University Health Network, Toroto, ON, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada
| | - B Zagorski
- UT Texas Health San Antonio, San Antonio, TX; Faculty of Medicine, University of Toronto, Toronto, ON, Canada; Princess Margaret Cancer Center, University Health Network, Toroto, ON, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada
| | - W Leong
- UT Texas Health San Antonio, San Antonio, TX; Faculty of Medicine, University of Toronto, Toronto, ON, Canada; Princess Margaret Cancer Center, University Health Network, Toroto, ON, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada
| | - M Vranic
- UT Texas Health San Antonio, San Antonio, TX; Faculty of Medicine, University of Toronto, Toronto, ON, Canada; Princess Margaret Cancer Center, University Health Network, Toroto, ON, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada
| | - A Fyles
- UT Texas Health San Antonio, San Antonio, TX; Faculty of Medicine, University of Toronto, Toronto, ON, Canada; Princess Margaret Cancer Center, University Health Network, Toroto, ON, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada
| | - A Vitkin
- UT Texas Health San Antonio, San Antonio, TX; Faculty of Medicine, University of Toronto, Toronto, ON, Canada; Princess Margaret Cancer Center, University Health Network, Toroto, ON, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada
| | - T Cil
- UT Texas Health San Antonio, San Antonio, TX; Faculty of Medicine, University of Toronto, Toronto, ON, Canada; Princess Margaret Cancer Center, University Health Network, Toroto, ON, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada
| | - D McCready
- UT Texas Health San Antonio, San Antonio, TX; Faculty of Medicine, University of Toronto, Toronto, ON, Canada; Princess Margaret Cancer Center, University Health Network, Toroto, ON, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada
| |
Collapse
|
4
|
Latchana N, Davis L, Coburn NG, Mahar A, Liu Y, Hammad A, Kagedan D, Elmi M, Siddiqui M, Earle CC, Hallet J. Population-based study of the impact of surgical and adjuvant therapy at the same or a different institution on survival of patients with pancreatic adenocarcinoma. BJS Open 2018; 3:85-94. [PMID: 30734019 PMCID: PMC6354229 DOI: 10.1002/bjs5.50115] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/04/2018] [Accepted: 09/18/2018] [Indexed: 12/21/2022] Open
Abstract
Background Pancreatic cancer surgery is increasingly regionalized in high‐volume centres. Provision of adjuvant chemotherapy in the same institution can place a burden on patients, whereas receiving adjuvant chemotherapy at a different institution closer to home may create disparities in care. This study compared long‐term outcomes of patients with pancreatic adenocarcinoma receiving adjuvant chemotherapy at the institution where they had undergone surgery with outcomes for those receiving chemotherapy at a different institution. Methods This was a population‐based study of patients receiving adjuvant chemotherapy after resection of pancreatic adenocarcinoma performed at ten designated hepatopancreatobiliary centres in Ontario, Canada, between 2004 and 2014. Patients were divided into those receiving chemotherapy at the same institution as surgery or a different institution from where surgery was performed. The primary outcome was overall survival (OS). Multivariable Cox regression assessed the association between OS and each chemotherapy group, adjusted for potential confounders. Results Of 589 patients, 374 (63·5 per cent) received adjuvant chemotherapy at the same institution as surgery. After adjusting for age, sex, co‐morbidity, socioeconomic status, rural living, tumour stage, margin positivity and year of surgery, the location of adjuvant chemotherapy was not independently associated with OS (hazard ratio 1·03, 95 per cent c.i. 0·85 to 1·24). For patients who underwent chemotherapy at a different institution, mean travel distance to receive chemotherapy was less (22·9 km) than that needed for surgery (106·7 km). Conclusion After pancreatectomy for pancreatic adenocarcinoma at specialized hepatopancreatobiliary surgery centres, OS was not affected by the location of the centre delivering adjuvant chemotherapy. Receiving this treatment in a local centre reduced patients' travel burden.
Collapse
Affiliation(s)
- N Latchana
- Department of Surgery, University of Toronto, Toronto, Ontario, Canada.,Division of General Surgery, Odette Cancer Centre - Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
| | - L Davis
- Sunnybrook Research Institute, Toronto, Ontario, Canada
| | - N G Coburn
- Department of Surgery, University of Toronto, Toronto, Ontario, Canada.,Division of General Surgery, Odette Cancer Centre - Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.,Sunnybrook Research Institute, Toronto, Ontario, Canada.,Institute of Clinical Evaluative Sciences, Toronto, Ontario, Canada
| | - A Mahar
- Department of Community Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada
| | - Y Liu
- Institute of Clinical Evaluative Sciences, Toronto, Ontario, Canada
| | - A Hammad
- Sunnybrook Research Institute, Toronto, Ontario, Canada.,Department of General Surgery, Mansoura University, Mansoura, Egypt
| | - D Kagedan
- Department of Surgery, University of Toronto, Toronto, Ontario, Canada
| | - M Elmi
- Department of Surgery, University of Toronto, Toronto, Ontario, Canada
| | - M Siddiqui
- Sunnybrook Research Institute, Toronto, Ontario, Canada
| | - C C Earle
- Department of Medicine, University of Toronto, Toronto, Ontario, Canada.,Institute of Clinical Evaluative Sciences, Toronto, Ontario, Canada.,Ontario Institute for Cancer Research, Toronto, Ontario, Canada
| | - J Hallet
- Department of Surgery, University of Toronto, Toronto, Ontario, Canada.,Division of General Surgery, Odette Cancer Centre - Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.,Sunnybrook Research Institute, Toronto, Ontario, Canada.,Institute of Clinical Evaluative Sciences, Toronto, Ontario, Canada
| |
Collapse
|
5
|
Mahar AL, El-Sedfy A, Dixon M, Siddiqui M, Elmi M, Ritter A, Vasilevska-Ristovska J, Jeong Y, Helyer L, Law C, Zagorski B, Coburn NG. Geographic variation in surgical practice patterns and outcomes for resected nonmetastatic gastric cancer in Ontario. ACTA ACUST UNITED AC 2018; 25:e436-e443. [PMID: 30464695 DOI: 10.3747/co.25.3953] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
Abstract
Background Gastrectomy with negative resection margins and adequate lymph node dissection is the cornerstone of curative treatment for gastric cancer (gc). However, gastrectomy is a complex and invasive operation with significant morbidity and mortality. Little is known about surgical practice patterns or short- and long-term outcomes in early-stage gc in Canada. Methods We undertook a population-based retrospective cohort study of patients with gc diagnosed between 1 April 2005 and 31 March 2008. Chart review provided clinical and operative details such as disease stage, primary tumour location, surgical approach, operation, lymph nodes, and resection margins. Administrative data provided patient demographics, geography, and vital status. Variations in treatment and outcomes were compared for 14 local health integration networks. Descriptive statistics and log-rank tests were used to examine geographic variation. Results We identified 722 patients with nonmetastatic resected gc. We documented significant provincial variation in case mix, including primary tumour location, stage at diagnosis, and tumour grade. Short-term surgical outcomes varied across the province. The percentage of patients with 15 or fewer lymph nodes removed and examined varied from 41.8% to 73.8% (p = 0.02), and the rate of positive surgical margins ranged from 15.2% to 50.0% (p = 0.002). The 30-day surgical mortality rates did not vary statistically significantly across the province (p = 0.13); however, rates ranged from 0% to 16.7%. Overall 5-year survival was 44% and ranged from 31% to 55% across the province. Conclusions This cohort of patients with resected stages i-iii gc is the largest analyzed in Canada, providing important historical information about treatment outcomes. Understanding the causes of regional variation will support interventions aiming to improve gc operative outcomes in the cancer system.
Collapse
Affiliation(s)
- A L Mahar
- Department of Community Health Sciences, University of Manitoba, Winnipeg, MB.,Institute for Clinical Evaluative Sciences, University of Toronto, Toronto, ON
| | - A El-Sedfy
- Department of Community Health Sciences, University of Manitoba, Winnipeg, MB
| | - M Dixon
- Department of Community Health Sciences, University of Manitoba, Winnipeg, MB.,Department of Surgery, University of Toronto, Toronto, ON
| | - M Siddiqui
- Department of Community Health Sciences, University of Manitoba, Winnipeg, MB
| | - M Elmi
- Department of Community Health Sciences, University of Manitoba, Winnipeg, MB
| | - A Ritter
- Department of Community Health Sciences, University of Manitoba, Winnipeg, MB
| | | | - Y Jeong
- Department of Community Health Sciences, University of Manitoba, Winnipeg, MB.,Institute for Clinical Evaluative Sciences, University of Toronto, Toronto, ON.,Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, ON
| | - L Helyer
- Department of Surgery, Dalhousie University, Halifax, NS
| | - C Law
- Department of Surgery, University of Toronto, Toronto, ON.,Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, ON.,Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON
| | - B Zagorski
- Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, ON
| | - N G Coburn
- Department of Surgery, University of Toronto, Toronto, ON.,Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, ON.,Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON
| |
Collapse
|
6
|
Elmi M, Sirigireddy B, Abukar J, Tchipeva D, Chauhan N, Tsitsikas DA. "Low platelet usage" haematology laboratories: To store or not to store? PLoS One 2017; 12:e0187340. [PMID: 29131870 PMCID: PMC5683636 DOI: 10.1371/journal.pone.0187340] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2017] [Accepted: 10/18/2017] [Indexed: 11/18/2022] Open
Abstract
In the UK, hospitals with annual platelet use of less than 500 pools, like our institution, usually do not store platelets on-site and these are only ordered from the national blood service (NBS) when a transfusion is required. In 2016, we piloted routine on-site storage of one pool of A RhD negative PLT. Data were collected retrospectively on units of PLTs ordered from NBS, units transfused to patients, wastage, requirements for emergency deliveries from NBS and overall cost. These were compared to corresponding data from the four preceding years (2012-2015). There was a 39% reduction in the PLT ordered from NBS in 2016 compared to previous years and a 50% reduction in transfused PLT. Annual wastage for 2016 increased by 23% even though the absolute number of wasted PLT did not alter significantly. Annual cost reduced by 36% in 2016 resulting from reduction in the total amount of PLTs ordered as well as reduction in emergency deliveries.
Collapse
Affiliation(s)
- M. Elmi
- Haematology & Blood Transfusion Department, Homerton University Hospital NHS Foundation Trust, London, United Kingdom
| | - B. Sirigireddy
- Haematology & Blood Transfusion Department, Homerton University Hospital NHS Foundation Trust, London, United Kingdom
| | - J. Abukar
- Haematology & Blood Transfusion Department, Homerton University Hospital NHS Foundation Trust, London, United Kingdom
| | - D. Tchipeva
- Haematology & Blood Transfusion Department, Homerton University Hospital NHS Foundation Trust, London, United Kingdom
| | - N. Chauhan
- Haematology & Blood Transfusion Department, Homerton University Hospital NHS Foundation Trust, London, United Kingdom
| | - D. A. Tsitsikas
- Haematology & Blood Transfusion Department, Homerton University Hospital NHS Foundation Trust, London, United Kingdom
- * E-mail:
| |
Collapse
|
7
|
Abstract
BACKGROUND The Odette Cancer Centre's recent implementation of a rapid diagnostic unit (rdu) for breast lesions has significantly decreased wait times to diagnosis. However, the economic impact of the unit remains unknown. This project defined the development and implementation costs and the operational costs of a breast rdu in a tertiary care facility. METHODS From an institutional perspective, a budget impact analysis identified the direct costs associated with the breast rdu. A base-case model was also used to calculate the cost per patient to achieve a diagnosis. Sensitivity analyses computed costs based on variations in key components. Costs are adjusted to 2015 valuations using health care-specific consumer price indices and are reported in Canadian dollars. RESULTS Initiation cost for the rdu was $366,243. The annual operational cost for support staff was $111,803. The average per-patient clinical cost for achieving a diagnosis was $770. Sensitivity analyses revealed that, if running at maximal institutional capacity, the total annual clinical cost for achieving a diagnosis could range between $136,080 and $702,675. CONCLUSIONS Establishment and maintenance of a breast rdu requires significant investment to achieve reductions in time to diagnosis. Expenditures ought to be interpreted in the context of institutional patient volumes and trade-offs in patient-centred outcomes, including lessened patient anxiety and possibly shorter times to definitive treatment. Our study can be used as a resource-planning tool for future rdus in health care systems wishing to improve diagnostic efficiency.
Collapse
Affiliation(s)
- M Elmi
- Division of General Surgery, Sunnybrook Health Sciences Centre-Odette Cancer Centre.,Department of Surgery, University of Toronto
| | - H Hussein
- Division of Breast Imaging, Sunnybrook Health Sciences Centre; and.,Department of Medical Imaging, University of Toronto, Toronto, ON; and.,Department of Medical Imaging, Cairo University, Cairo, Egypt
| | - S Nofech-Mozes
- Division of General Surgery, Sunnybrook Health Sciences Centre-Odette Cancer Centre
| | - B Curpen
- Division of Breast Imaging, Sunnybrook Health Sciences Centre; and.,Department of Medical Imaging, University of Toronto, Toronto, ON; and
| | - A Leahey
- Division of General Surgery, Sunnybrook Health Sciences Centre-Odette Cancer Centre
| | - N Look Hong
- Division of General Surgery, Sunnybrook Health Sciences Centre-Odette Cancer Centre.,Department of Surgery, University of Toronto
| |
Collapse
|
8
|
Barbas AS, Elmi M, Fischer S, Sapisochin G. Painful Groin Mass in a Liver Transplant Recipient. Am J Transplant 2017. [DOI: 10.1111/ajt.14079] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- A. S. Barbas
- Multi-Organ Transplant Program; University of Toronto; Toronto Ontario Canada
| | - M. Elmi
- Multi-Organ Transplant Program; University of Toronto; Toronto Ontario Canada
| | - S. Fischer
- Laboratory Medicine Program; University of Toronto; Toronto Ontario Canada
| | - G. Sapisochin
- Multi-Organ Transplant Program; University of Toronto; Toronto Ontario Canada
| |
Collapse
|
9
|
Kagedan DJ, Dixon ME, Raju RS, Li Q, Elmi M, Shin E, Liu N, El-Sedfy A, Paszat L, Kiss A, Earle CC, Mittmann N, Coburn NG. Predictors of adjuvant treatment for pancreatic adenocarcinoma at the population level. ACTA ACUST UNITED AC 2016; 23:334-342. [PMID: 27803598 DOI: 10.3747/co.23.3205] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
BACKGROUND In the present study, we aimed to describe, at the population level, patterns of adjuvant treatment use after curative-intent resection for pancreatic adenocarcinoma (pcc) and to identify independent predictors of adjuvant treatment use. METHODS In this observational cohort study, patients undergoing pcc resection in the province of Ontario (population 13 million) during 2005-2010 were identified using the provincial cancer registry and were linked to administrative databases that include all treatments received and outcomes experienced in the province. Patients were defined as having received chemotherapy (ctx), chemoradiation (crt), or observation (obs). Clinicopathologic factors associated with the use of ctx, crt, or obs were identified by chi-square test. Logistic regression analyses were used to identify independent predictors of adjuvant treatment versus obs, and ctx versus crt. RESULTS Of the 397 patients included, 75.3% received adjuvant treatment (27.2% crt, 48.1% ctx) and 24.7% received obs. Within a single-payer health care system with universal coverage of costs for ctx and crt, substantial variation by geographic region was observed. Although the likelihood of receiving adjuvant treatment increased from 2005 to 2010 (p = 0.002), multivariate analysis revealed widespread variation between the treating hospitals (p = 0.001), and even between high-volume hepatopancreatobiliary hospitals (p = 0.0006). Younger age, positive lymph nodes, and positive surgical resection margins predicted an increased likelihood of receiving adjuvant treatment. Among patients receiving adjuvant treatment, positive margins and a low comorbidity burden were associated with crt compared with ctx. CONCLUSIONS Interinstitutional medical practice variation contributes significantly to differential patterns in the rate of adjuvant treatment for pcc. Whether such variation is warranted or unwarranted requires further investigation.
Collapse
Affiliation(s)
- D J Kagedan
- Division of General Surgery, Department of Surgery, University of Toronto, Toronto, ON
| | - M E Dixon
- Department of Surgery, Maimonides Medical Center, Brooklyn, NY, U.S.A
| | - R S Raju
- Sunnybrook Health Sciences Centre
| | - Q Li
- Institute for Clinical Evaluative Sciences and
| | - M Elmi
- Division of General Surgery, Department of Surgery, University of Toronto, Toronto, ON
| | - E Shin
- Faculty of Medicine, University of Toronto, Toronto, ON
| | - N Liu
- Institute for Clinical Evaluative Sciences and
| | - A El-Sedfy
- Department of Surgery, Saint Barnabas Medical Center, Livingston, NJ, U.S.A
| | - L Paszat
- Sunnybrook Health Sciences Centre; Institute for Clinical Evaluative Sciences and; Faculty of Medicine, University of Toronto, Toronto, ON
| | - A Kiss
- Sunnybrook Health Sciences Centre; Institute for Clinical Evaluative Sciences and; Institute of Health Policy, Management and Evaluation, University of Toronto and
| | - C C Earle
- Sunnybrook Health Sciences Centre; Institute for Clinical Evaluative Sciences and; Faculty of Medicine, University of Toronto, Toronto, ON
| | | | - N G Coburn
- Division of General Surgery, Department of Surgery, University of Toronto, Toronto, ON;; Sunnybrook Health Sciences Centre; Institute for Clinical Evaluative Sciences and; Faculty of Medicine, University of Toronto, Toronto, ON;; Institute of Health Policy, Management and Evaluation, University of Toronto and
| |
Collapse
|
10
|
Kagedan DJ, Frankul F, El-Sedfy A, McGregor C, Elmi M, Zagorski B, Dixon ME, Mahar AL, Vasilevska-Ristovska J, Helyer L, Rowsell C, Swallow CJ, Law CH, Coburn NG. Negative predictive value of preoperative computed tomography in determining pathologic local invasion, nodal disease, and abdominal metastases in gastric cancer. ACTA ACUST UNITED AC 2016; 23:273-9. [PMID: 27536178 DOI: 10.3747/co.23.3124] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/16/2023]
Abstract
BACKGROUND Before undergoing curative-intent resection of gastric adenocarcinoma (ga), most patients undergo abdominal computed tomography (ct) imaging to determine contraindications to resection (local invasion, distant metastases). However, the ability to detect contraindications is variable, and the literature is limited to single-institution studies. We sought to assess, on a population level, the clinical relevance of preoperative ct in evaluating the resectability of ga tumours in patients undergoing surgery. METHODS In a provincial cancer registry, 2414 patients with ga diagnosed during 2005-2008 at 116 institutions were identified, and a primary chart review of radiology, operative, and pathology reports was performed for all patients. Preoperative abdominal ct reports were compared with intraoperative findings and final pathology reports (reference standard) to determine the negative predictive value (npv) of ct in assessing local invasion, nodal involvement, and intra-abdominal metastases. RESULTS Among patients undergoing gastrectomy, the npv of ct imaging in detecting local invasion was 86.9% (n = 536). For nodal metastasis, the npv of ct was 43.3% (n = 450). Among patients undergoing surgical exploration, the npv of ct for intra-abdominal metastases was 52.3% (n = 407). CONCLUSIONS Preoperative abdominal ct imaging reported as negative is most accurate in determining local invasion and least accurate in nodal assessment. The poor npv of ct should be taken into account when selecting patients for staging laparoscopy.
Collapse
Affiliation(s)
- D J Kagedan
- Division of General Surgery, Department of Surgery, University of Toronto, Toronto, ON; Department of General Surgery, Sunnybrook Health Sciences Centre, Toronto, ON; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON
| | - F Frankul
- Department of General Surgery, Sunnybrook Health Sciences Centre, Toronto, ON
| | - A El-Sedfy
- Department of Surgery, Saint Barnabas Medical Center, Livingston, NJ, U.S.A
| | - C McGregor
- Department of Medical Imaging, Sunnybrook Health Sciences Centre, Toronto, ON
| | - M Elmi
- Division of General Surgery, Department of Surgery, University of Toronto, Toronto, ON; Department of General Surgery, Sunnybrook Health Sciences Centre, Toronto, ON; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON
| | - B Zagorski
- Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON
| | - M E Dixon
- Department of Surgery, Maimonides Medical Center, Brooklyn, NY, U.S.A
| | - A L Mahar
- Department of Public Health Sciences, Queen's University, Kingston, ON
| | | | - L Helyer
- Division of General Surgery, Dalhousie University, Halifax, NS
| | - C Rowsell
- Department of Anatomic Pathology, Sunnybrook Health Sciences Centre, Toronto, ON
| | - C J Swallow
- Division of General Surgery, Department of Surgery, University of Toronto, Toronto, ON
| | - C H Law
- Division of General Surgery, Department of Surgery, University of Toronto, Toronto, ON; Department of General Surgery, Sunnybrook Health Sciences Centre, Toronto, ON; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON
| | - N G Coburn
- Division of General Surgery, Department of Surgery, University of Toronto, Toronto, ON; Department of General Surgery, Sunnybrook Health Sciences Centre, Toronto, ON; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON
| |
Collapse
|
11
|
Elmi M. Food safety: current situation, unaddressed issues and the emerging priorities. East Mediterr Health J 2004; 10:794-800. [PMID: 16335766] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/05/2023]
Abstract
This paper reviews the topic of food safety with reference to the Eastern Mediterranean Region. The differing views of food safety and the current situation with regard to ensuring food safety are presented. Also discussed are some of the unaddressed issues and challenges related to food safety. The new conditions that have arisen in the modern world which have facilitated the emergence of pathogens are presented, such as changes in animal husbandry, changes in international trade and travel, lifestyle and consumer changes. The urgent need for action in order to reduce the risk of microbiological and chemical foodborne diseases is emphasized. The food chain starts from farm and ends at fork; controlling this complex process requires an integrated approach and a responsible authority to oversee it in order to protect and promote food safety.
Collapse
Affiliation(s)
- M Elmi
- Food and Chemical Safety, WHO Regional Office for the Eastern Mediterranean, Cairo, Egypt
| |
Collapse
|
12
|
Abstract
This paper reviews the topic of food safety with reference to the Eastern Mediterranean Region. The differing views of food safety and the current situation with regard to ensuring food safety are presented. Also discussed are some of the unaddressed issues and challenges related to food safety. The new conditions that have arisen in the modern world which have facilitated the emergence of pathogens are presented, such as changes in animal husb and ry, changes in international trade and travel, lifestyle and consumer changes. The urgent need for action in order to reduce the risk of microbiological and chemical foodborne diseases is emphasized. The food chain starts from farm and ends at fork; controlling this complex process requires an integrated approach and a responsible authority to oversee it in order to protect and promote food safety
Collapse
|
13
|
Brederlau A, Faigle R, Elmi M, Zarebski A, Sjöberg S, Fujii M, Miyazono K, Funa K. The bone morphogenetic protein type Ib receptor is a major mediator of glial differentiation and cell survival in adult hippocampal progenitor cell culture. Mol Biol Cell 2004; 15:3863-75. [PMID: 15194807 PMCID: PMC491842 DOI: 10.1091/mbc.e03-08-0584] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022] Open
Abstract
Bone morphogenetic proteins (BMPs) act as growth regulators and inducers of differentiation. They transduce their signal via three different type I receptors, termed activin receptor-like kinase 2 (Alk2), Alk3, or bone morphogenetic protein receptor Ia (BMPRIa) and Alk6 or BMPRIb. Little is known about functional differences between the three type I receptors. Here, we have investigated consequences of constitutively active (ca) and dominant negative (dn) type I receptor overexpression in adult-derived hippocampal progenitor cells (AHPs). The dn receptors have a nonfunctional intracellular but functional extracellular domain. They thus trap BMPs that are endogenously produced by AHPs. We found that effects obtained by overexpression of dnAlk2 and dnAlk6 were similar, suggesting similar ligand binding patterns for these receptors. Thus, cell survival was decreased, glial fibrillary acidic protein (GFAP) expression was reduced, whereas the number of oligodendrocytes increased. No effect on neuronal differentiation was seen. Whereas the expression of Alk2 and Alk3 mRNA remained unchanged, the Alk6 mRNA was induced after impaired BMP signaling. After dnAlk3 overexpression, cell survival and astroglial differentiation increased in parallel to augmented Alk6 receptor signaling. We conclude that endogenous BMPs mediate cell survival, astroglial differentiation and the suppression of oligodendrocytic cell fate mainly via the Alk6 receptor in AHP culture.
Collapse
Affiliation(s)
- A Brederlau
- Institute of Anatomy and Cell Biology, Göteborg University, SE-405 30 Gothenburg, Sweden.
| | | | | | | | | | | | | | | |
Collapse
|